Gong Chunli, Yang Huan, Wang Sumin, Liu Jiao, Li Zhibin, Hu Yiyang, Chen Yang, Huang Yu, Luo Qiang, Wu Yuyun, Liu En, Xiao Yufeng
Department of Gastroenterology, Xinqiao Hospital, Third Military Medical University, Chongqing, China.
Department of Endoscope, General Hospital of Shenyang Military Region, Shenyang, China.
Front Cell Dev Biol. 2021 May 17;9:658101. doi: 10.3389/fcell.2021.658101. eCollection 2021.
High human telomerase reverse transcriptase (hTERT) expression is related to severe Colorectal Cancer (CRC) progression and negatively related to CRC patient survival. Previous studies have revealed that hTERT can reduce cancer cellular reactive oxygen species (ROS) levels and accelerate cancer progression; however, the mechanism remains poorly understood. NFE2-related factor 2 (NRF2) is a molecule that plays a significant role in regulating cellular ROS homeostasis, but whether there is a correlation between hTERT and NRF2 remains unclear. Here, we showed that hTERT increases CRC proliferation and migration by inducing NRF2 upregulation. We further found that hTERT increases NRF2 expression at both the mRNA and protein levels. Our data also revealed that hTERT primarily upregulates NRF2 by increasing NRF2 promoter activity rather than by regulating NRF2 mRNA or protein stability. Using DNA pull-down/MS analysis, we found that hTERT can recruit YBX1 to upregulate NRF2 promoter activity. We also found that hTERT/YBX1 may localize to the P2 region of the NRF2 promoter. Taken together, our results demonstrate that hTERT facilitates CRC proliferation and migration by upregulating NRF2 expression through the recruitment of the transcription factor YBX1 to activate the NRF2 promoter. These results provide a new theoretical basis for CRC treatment.
人端粒酶逆转录酶(hTERT)的高表达与严重的结直肠癌(CRC)进展相关,与CRC患者的生存率呈负相关。先前的研究表明,hTERT可以降低癌细胞活性氧(ROS)水平并加速癌症进展;然而,其机制仍知之甚少。核因子E2相关因子2(NRF2)是一种在调节细胞ROS稳态中起重要作用的分子,但hTERT与NRF2之间是否存在关联仍不清楚。在此,我们表明hTERT通过诱导NRF2上调来增加CRC的增殖和迁移。我们进一步发现,hTERT在mRNA和蛋白质水平上均增加NRF2的表达。我们的数据还显示,hTERT主要通过增加NRF2启动子活性来上调NRF2,而不是通过调节NRF2 mRNA或蛋白质稳定性。使用DNA下拉/质谱分析,我们发现hTERT可以招募YBX1来上调NRF2启动子活性。我们还发现hTERT/YBX1可能定位于NRF2启动子的P2区域。综上所述,我们的结果表明,hTERT通过招募转录因子YBX1激活NRF2启动子来上调NRF2表达,从而促进CRC的增殖和迁移。这些结果为CRC治疗提供了新的理论依据。